Neppert J, Clemens M, Mueller-Eckhardt C
Blut. 1986 Feb;52(2):67-72. doi: 10.1007/BF00321069.
Sixteen commercially available immunoglobulins (Ig) and 5 anti-Rho (D) hyperimmune globulins were investigated for immune phagocytosis inhibition (IPI) factors as well as for T, B lymphocytotoxic and monocytotoxic antibodies. All Ig contained IPI factors with lowest inhibitory IgG concentrations ranging from 0.08 to 50 mg/ml. Pepsin-digested Ig was noninhibitory. IPI factors in anti-D preparations were uniformly high (inhibitory IgG concentrations 0.6-2.5 mg/ml). Cytotoxic antibodies against T, B lymphocytes and monocytes were found in 2,2 and 7 products, respectively. Since we have recently shown that IPI is caused by antibodies against major histocompatibility complex antigens, most likely HLA, the hypothesis is put forward that IPI factors in Ig are HLA-related, cytotoxic as well as noncytotoxic antibodies which act via Fc receptor blockade of human monocytes.
对16种市售免疫球蛋白(Ig)和5种抗Rho(D)高效价免疫球蛋白进行了研究,以检测其免疫吞噬抑制(IPI)因子以及T、B淋巴细胞毒性和单核细胞毒性抗体。所有Ig均含有IPI因子,最低抑制性IgG浓度范围为0.08至50mg/ml。经胃蛋白酶消化的Ig无抑制作用。抗D制剂中的IPI因子普遍较高(抑制性IgG浓度为0.6 - 2.5mg/ml)。分别在2种、2种和7种产品中发现了针对T、B淋巴细胞和单核细胞的细胞毒性抗体。由于我们最近表明IPI是由针对主要组织相容性复合体抗原(最有可能是HLA)的抗体引起的,因此提出了这样的假设:Ig中的IPI因子是与HLA相关的细胞毒性和非细胞毒性抗体,它们通过阻断人单核细胞的Fc受体发挥作用。